PeproTech Recombinant Human M-CSF
- 發(fā)布日期： 2025-12-24
- 更新日期： 2026-03-12
產(chǎn)品詳請(qǐng)
| 產(chǎn)地 |
|
| 品牌 |
PeproTech
|
| 貨號(hào) |
300-25-2UG
|
| 用途 |
重組蛋白
|
| 包裝規(guī)格 |
/
|
| CAS編號(hào) |
|
| 純度 |
/%
|
| 是否進(jìn)口 |
|
產(chǎn)品描述：
M-CSF is a potent hematopoietic factor produced by a variety of cells, including lymphocytes, monocytes, fibroblasts, endothelial cells, myoblasts and osteoblasts. It is a key regulator of cellular proliferation, differentiation, and survival for blood monocytes, tissue macrophages, and their respective progenitor cells. M-CSF has been shown to play important roles in modulating dermal thickness and fertility. M-CSF is clinically used in the treatment of infection, malignancies and atherosclerosis. It facilitates hematopoietic recovery after bone marrow transplantation. Human M-CSF is reactive in murine systems, but the murine molecule exhibits no activity on human cells. Recombinant Human M-CSF is a 36.8 kDa homodimeric protein consisting of two 159 amino acid polypeptide subunits.
來(lái)源:E.coli
別名:Macrophage Colony Stimulating Factor, CSF-1, MGI-IM
氨基酸序列:
MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS
純度:≥ 98% by SDS-PAGE gel and HPLC analyses.
生物活性:The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 106 units/mg.
Calculated Molecular Weight:36.8 kDa
Accession Number:P09603
Gene ID:1435
交叉反應(yīng)：
Human, Human + Cow, Human + Hamster, Human + Virus, Monkey, Mouse, Rabbit, Rat
原產(chǎn)國(guó): USA
訂購(gòu)信息：
| 300-25-2UG | Recombinant Human M-CSF | 2 ug |
| 300-25-10UG | Recombinant Human M-CSF | 10 ug |
| 300-25-50UG | Recombinant Human M-CSF | 50 ug |
| 300-25-100UG | Recombinant Human M-CSF | 100 ug |
| 300-25-250UG | Recombinant Human M-CSF | 250 ug |
| 300-25-500UG | Recombinant Human M-CSF | 500 ug |
| 300-25-1MG | Recombinant Human M-CSF | 1 mg |
| | | |
| 300-28A-2UG | Recombinant Human SDF-1alpha (CXCL12) | 2 ug |
| 300-28A-10UG | Recombinant Human SDF-1alpha (CXCL12) | 10 ug |
| 300-28A-50UG | Recombinant Human SDF-1alpha (CXCL12) | 50 ug |
| 300-28A-100UG | Recombinant Human SDF-1alpha (CXCL12) | 100 ug |
| 300-28A-250UG | Recombinant Human SDF-1alpha (CXCL12) | 250 ug |
| 300-28A-500UG | Recombinant Human SDF-1alpha (CXCL12) | 500 ug |
| 300-28A-1MG | Recombinant Human SDF-1alpha (CXCL12) | 1 mg |
| | | |
| 300-28B-2UG | Recombinant Human SDF-1beta (CXCL12) | 2 ug |
| 300-28B-10UG | Recombinant Human SDF-1beta (CXCL12) | 10 ug |
| 300-28B-50UG | Recombinant Human SDF-1beta (CXCL12) | 50 ug |
| 300-28B-100UG | Recombinant Human SDF-1beta (CXCL12) | 100 ug |
| 300-28B-250UG | Recombinant Human SDF-1beta (CXCL12) | 250 ug |
| 300-28B-500UG | Recombinant Human SDF-1beta (CXCL12) | 500 ug |
| 300-28B-1MG | Recombinant Human SDF-1beta (CXCL12) | 1 mg |
| | | |
| | | |
| 100-18B-10UG | Recombinant Human FGF-basic (154 a.a.) | 10 ug |
| 100-18B-50UG | Recombinant Human FGF-basic (154 a.a.) | 50 ug |
| 100-18B-100UG | Recombinant Human FGF-basic (154 a.a.) | 100 ug |
| 100-18B-250UG | Recombinant Human FGF-basic (154 a.a.) | 250 ug |
| 100-18B-500UG | Recombinant Human FGF-basic (154 a.a.) | 500 ug |
| 100-18B-1MG | Recombinant Human FGF-basic (154 a.a.) | 1 mg |
